Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI)-Renalytix Plc
-
Form 8.5 (EPT/RI)-Alpha Financial Markets Consulting Plc
-
Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates
-
Inventiva announces a €20.1 million issuance of royalty certificates
-
OKX Compound DeFi Bonus Reaches 150M Milestone
-
Company announcement no 14/2024 - June 2024 Sales price
-
-
valantic FSA sign with Nasdaq to develop Web UI for Fixed Income Markets
-
Introducing Three Protocol: Building An Alternative To Centralized Digital ID's and KYC with No-KYC Zero Knowledge Proof, Decentralized Digital ID's
-
Introducing Three Protocol: Building An Alternative To Centralized Digital ID's and KYC with No-KYC Zero Knowledge Proof, Decentralized Digital ID's
-
Aspocomp’s Half-Year Report 2024: Net sales and operating result decreased in the second quarter, orders received turned to growth
-
Innofactor Plc’s Half-Yearly Report for January 1–June 30, 2024 (IFRS)
-
Pharming Group to report second quarter and first half 2024 financial results on August 1
-
Transaction in Own Shares
-
Intermediate Capital Group plc: Block Listing Six Monthly
-
AS Tallink Grupp will hold an Investor Webinar to introduce the results of the second quarter of 2024
-
OKX Wallet Now Integrated with Fun Worlds Gaming Platform
-
OKX Wallet Now Integrated with Game7 Platform
-
Crossject achieves key ZEPIZURE® manufacturing milestone
-
Nearfield Instruments secures €135 million in landmark deep-tech funding round
-
TRAINERS’ HOUSE GROUP HALF YEAR REPORT 1 JANUARY – 30 JUNE 2024
-
Renault Group 2024 H1 sales results: Renault Group continues to grow thanks to its complementary brands
-
Crossject achieves key ZEPIZURE® manufacturing milestone
-
BGHL (EUR): NAV(s)
-
BGHL (GBP): NAV(s)
-
Sampo plc’s share buybacks 17 July 2024
-
Nicox Provides Second Quarter 2024 Update
-
DNA Plc’s Half-Year Financial Report 2024: Total revenues, EBITDA, and operating result continued to improve
-
Viridien Announces its Q2 Financial Results on Tuesday 30th July 2024, after Market Close
-
Publicis Groupe : First Half 2024 Results
-
OKX Wallet Now Integrated with Iskra Gaming Platform
-
New plan period in the long-term incentive scheme directed to Aspocomp’s management
-
TGS Quarterly Dividend
-
Telenor continues to deliver on security offering and growth
-
BAWAG Group publishes Q2 2024 results: Net profit € 175 million and RoTCE 24.3%
-
Nokia Corporation Report for Q2 and Half Year 2024
-
Start of Day Message
-
Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance
-
Hexagon Purus ASA: Results for the second quarter 2024
-
TGS Announces Q2 2024 Results
-
Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabeti
-
BioSenic releases new in-depth analysis of its positive phase 2 clinical data for optimal administration scheme for its next late-stage trial of arsenic trioxide (ATO) targeting cGvHD
-
argenx to Report Half Year 2024 Financial Results and Second Quarter Business Update on July 25, 2024
-
Verkkokauppa.com Oyj HALF-YEAR REPORT for 1 January – 30 June 2024: Low demand and intense price competition weakened Verkkokauppa.com's profitability
-
Telia Lietuva results for 6 months of 2024
-
Coop Pank unaudited financial results for Q2 2024
-
TGS Announces Extension to its Ocean Bottom Node Acquisition Campaign in West Africa
-
Most small SUVs perform well in rear autobrake evaluation
-
Junshi Biosciences Announces the Acceptance of the Supplemental New Drug Application for Toripalimab Combined with Bevacizumab for the First-Line Treatment of Advanced Hepatocellular Carcinoma
-
SAI.TECH Global Corporation Announces Share Repurchase Program
